-Live Mint There are also ways in which we can help Indian institutions that have come to us seeking access to our technologies Bangalore: A key perception change is emerging in the global pharmaceutical industry on the long-established divide between the so-called generics and innovative business. While the two are still at loggerheads in several developed as well as developing markets, the world’s top drugmakers are reinventing the wheel. Paris-based Sanofi SA,...
More »SEARCH RESULT
India’s tuberculosis challenge -R Prasad
-The Hindu The epidemic is running amok. And the government is finally waking up to the reality. Tuberculosis was declared a global health emergency in 1993, but it has been growing unchecked. Today, TB is causing millions of deaths every year globally. Like any infectious disease, TB is prevalent even in developed countries. But it is a more serious problem in the developing and populous countries. India and China together account for nearly...
More »Flunking Atomic Audits-MV Ramana
-Economic and Political Weekly The recent Comptroller and Auditor General's report on the Atomic Energy Regulatory Board and, more broadly, on nuclear safety regulation has highlighted many serious organisational and operational flaws. The report follows on a series of earlier CAG reports that documented cost and time overruns and poor performance at a number of nuclear facilities in the country. On the whole, the CAG reports offer a powerful indictment of...
More »Take this patient to ICU-Pushpa M Bhargava
A cure for India’s health care ills is within reach provided there is political will In most developed — and many developing — countries today, a 12-year school education and universal health coverage (UHC) are the two primary responsibilities of the state. India has failed miserably on both counts. Let us look at some of the problems of medical and health care: • Fifty years ago, when there was no commercialisation of...
More »In a victory for India and China, WHO evolves mechanism to define counterfeit drugs-Aarti Dhar
-The Hindu The World Health Organisation (WHO) has put in place a mechanism to define counterfeit medical products. The set of definitions of sub-standard, spurious, falsely labelled, falsified and counterfeit products will be globally accepted and help to bring about uniformity in identifying such drugs, without interrupting worldwide supplies. The decision to establish a member state mechanism was taken at the World Health Assembly, the WHO's policymaking body, at a meeting held recently. The...
More »